Results of comparing allergy groups within visits using KEGG pathway enrichment in ConsensusPathDB. od Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within treatment groups as determ... od Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using KEGG pathway enrichment in ConsensusPathDB. od Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within allergy groups as determin... od Diana M. Hendrickx (1507435)

Results of comparing visits within allergy groups using KEGG pathway enrichment in ConsensusPathDB. od Diana M. Hendrickx (1507435)

Potential mechanisms for persistent CMA (left) and resolution of CMA (right) revealed by our study. od Diana M. Hendrickx (1507435)

Nanoplastics Stimulate Colony Formation and Bloom in <i>Phaeocystis globosa</i> od Yingxia Li (385992)

“...The genus <i>Phaeocystis</i> is a globally distributed harmful alga that adversely impacts marine ecosystems. ...”

Supplementary file 1_Hard to jump: host shifts appear unlikely in a T4-like phage evolved in the lab.docx od Yu Ning (588573)

“...However, concerns remain regarding host shifts, where therapeutic phages could evolve to infect and harm beneficial commensal bacteria. ...”

Morality boundary work in the making of the needle and syringe exchange program in Stockholm od Lena Eriksson (48327)

“...Hence, users’ perspectives, and those who care about them, should be extensively involved in political discussions to foster a more moral and humane drug policy....”

Table 1_The evolving burden of drug use disorders: a comprehensive epidemiological analysis from the 2021 Global Burden of Disease study.xlsx od Yujuan Liu (718714)

Data Sheet 3_The evolving burden of drug use disorders: a comprehensive epidemiological analysis from the 2021 Global Burden of Disease study.pdf od Yujuan Liu (718714)

Data Sheet 4_The evolving burden of drug use disorders: a comprehensive epidemiological analysis from the 2021 Global Burden of Disease study.pdf od Yujuan Liu (718714)

Data Sheet 2_The evolving burden of drug use disorders: a comprehensive epidemiological analysis from the 2021 Global Burden of Disease study.pdf od Yujuan Liu (718714)

Data Sheet 7_The evolving burden of drug use disorders: a comprehensive epidemiological analysis from the 2021 Global Burden of Disease study.csv od Yujuan Liu (718714)

Data Sheet 1_The evolving burden of drug use disorders: a comprehensive epidemiological analysis from the 2021 Global Burden of Disease study.pdf od Yujuan Liu (718714)

Data Sheet 5_The evolving burden of drug use disorders: a comprehensive epidemiological analysis from the 2021 Global Burden of Disease study.pdf od Yujuan Liu (718714)

Data Sheet 6_The evolving burden of drug use disorders: a comprehensive epidemiological analysis from the 2021 Global Burden of Disease study.pdf od Yujuan Liu (718714)

NoMAD construct results for weeks 6/7 and 11/12. od Melanie Handley (16668024)

“...Qualitative and quantitative data involved: i) observations of staff-patient interactions (four time points), ii) in-depth interviews with hospital staff (one time point) iii) staff surveys (two time points). ...”

Participant recruitment by site. od Melanie Handley (16668024)

“...Qualitative and quantitative data involved: i) observations of staff-patient interactions (four time points), ii) in-depth interviews with hospital staff (one time point) iii) staff surveys (two time points). ...”

Table 1_Practitioners’ and researchers’ perspectives on treatment needs and service provision for online child sexual abuse.docx od Felipa Schmidt (17273704)